Skip to main content
OpenTrials
Completed

NCT Number: NCT05443113

Young Pectus Excavatum Patients and Genetic Defects

In most pectus excavatum (PE) patients an underlying genetic defect is not found with molecular analysis, as a direct genetic link with PE has yet to be found and because potential underlying genetic disorders are quite rare. Only one-fifth of all PE cases are identified in the first decade of life and thus of congenital origin making younger PE patients a unique patient group. Therefore, the research question is; is early-onset pectus excavatum (PE) more likely to be part of a genetic defect than PE which became apparent during puberty or adolescence?

Completed

Looking for future studies?

Notify Me

Key information

About this study

Importance: In most pectus excavatum (PE) patients an underlying genetic defect is not found with molecular analysis, as a direct genetic link with PE has yet to be found and because potential underlying genetic disorders are quite rare. Only one-fifth of all PE cases are identified in the first decade of life and thus of congenital origin making younger PE patients a unique patient group.

Objective: the investigators hypothesize that early-onset PE is more likely to be part of a genetic defect than PE which became apparent during puberty or adolescence.

Design: Cohort study Setting: Single center Participants: All pediatric PE patients aged younger than 11 years upon first visit of the outpatient clinic of the department of pediatric surgery at the Sophia Children's Hospital - Erasmus Medical Center between 2014 and 2020 were identified and informed consent was obtained for inclusion. Two clinical geneticists performed the anamnesis and physical examination. Molecular analysis was performed based on the differential diagnosis. All young PE patients which have been referred for genetic counseling already, were analyzed retrospectively.

Main Outcome: incidence of genetic defects

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with pectus excavatum aged younger than 11 years upon first visit of our outpatient clinic

Exclusion criteria

  • None

Treatment and study plan

Genetic analysis

Diagnostic Test

Genetic analysis by geneticists

Primary outcomes

  1. Incidence of genetic variations

    Time frame: Baseline

    Incidence of genetic variations in children (<11 years) with pectus excavatum

Secondary outcomes

  1. Evaluation checklist referral of a patient with pectus excavatum for genetic counseling

    Time frame: Through study completion, an average of 1 year

    Evaluation and validation of checklist referral of a patient with pectus excavatum for genetic counseling

Sponsors and collaborators

Lead sponsor

Erasmus Medical Center

Other

Registry information

Official study title

Early Onset Pectus Excavatum is More Likely to be Part of a Genetic Defect

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jul 5, 2022
Registry last updated
Jul 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.